ELDA BrainTech develops neurodiagnostic technologies that integrate electroencephalography (EEG) with magnetic resonance imaging (MRI) to improve localization of epileptic activity. The company’s platform combines an MRI-compatible EEG cap with software designed to analyze neural signals during simultaneous EEG–fMRI recordings. This integrated approach aims to enhance spatial and temporal resolution compared to standalone modalities. ELDA BrainTech positions its technology within regulated clinical and research environments.

The technology enables concurrent acquisition of EEG and fMRI data, capturing both electrical activity and hemodynamic responses associated with epileptic events. AI-driven analysis is applied to align and interpret multimodal signals, helping identify epileptogenic zones with greater precision. By correlating fast electrical discharges with localized brain activation patterns, the system supports more accurate mapping of seizure origins. The platform emphasizes compatibility with existing MRI workflows and clinical protocols.

ELDA BrainTech targets epilepsy diagnosis and pre-surgical evaluation, where precise localization of seizure foci is critical. The system is intended for use by clinicians and researchers in specialized epilepsy centers. Its positioning reflects broader efforts to combine multimodal neuroimaging and AI to improve diagnostic confidence and treatment planning in complex neurological conditions.